Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Titan Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 23 | +3 |
| Shares | 1.05M | 23 | 968.0K | −86.4K (−8.2%) |
| Value | $1.14M | $25 | $757.9K | −$378.1K (−33.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,612 | $1.00K | 0.00% |
| Group One Trading, L.P. | 303 | $237 | 0.00% |
| The PNC Financial Services Group, Inc. | 200 | $156 | 0.00% |
| Global Wealth Strategies & Associates | 40 | $31 | 0.00% |
| Caldwell Sutter Capital, Inc. | 2 | $2 | 0.00% |
| JPMorgan Chase & Co | 61 | $0 | 0.00% |
Sold out (3)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| FNY Investment Advisers, LLC | 28,025 | $30.0K |
| Millennium Management LLC | 17,467 | $19.0K |
| Citadel Advisors LLC | 13,076 | $14.0K |
Not filed for Q4 2022 yet (1)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| American Portfolios Advisors | 23 | $25 |